Jeena Sikho Lifecare Limited has informed the Exchange regarding Receipt of In-Principle Approvals for Migration from SME Platform to Main Board of NSE and BSE'.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeena Sikho Lifecare Limited has received in-principle approvals from NSE (on July 23, 2025) and BSE (on August 1, 2025) to migrate its equity shares from the NSE Emerge SME Platform to the Main Board of both stock exchanges. The migration covers 1,24,30,073 equity shares of Rs. 2 face value and is being done through the direct listing route. Both approvals are valid for 45 days, during which the company must submit its listing application, listing agreement, shareholding pattern, financial results, and applicable fees. After completing these formalities, the exchanges will issue the final approval for migration.
This is a positive milestone — moving from the SME platform to the Main Board typically expands the stock's visibility, brings in more institutional and retail participation, and may improve liquidity and valuation. Existing shareholders stand to benefit from broader market access once the migration is completed.